A gap with causes | Going Public 03/2020

German life science companies must raise more money abroad
The fact that Germany’s life science industry is doing very well in European comparison is due to a few big deals. The latest venture capital research by FCF Life Sciences shows a much different and quite disillusioning picture.
By Dr Mathias Schott and Sebastian Sommer